1. Home
  2. FSLY vs IRON Comparison

FSLY vs IRON Comparison

Compare FSLY & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$19.38

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$65.80

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLY
IRON
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FSLY
IRON
Price
$19.38
$65.80
Analyst Decision
Hold
Strong Buy
Analyst Count
8
11
Target Price
$18.00
$103.18
AVG Volume (30 Days)
7.8M
445.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.19
N/A
EPS
N/A
N/A
Revenue
$624,018,000.00
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
$10.73
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
14.78
N/A
52 Week Low
$6.29
$40.00
52 Week High
$34.82
$99.50

Technical Indicators

Market Signals
Indicator
FSLY
IRON
Relative Strength Index (RSI) 47.47 42.66
Support Level $16.06 $64.39
Resistance Level $20.27 $65.25
Average True Range (ATR) 1.49 3.04
MACD 0.48 -0.28
Stochastic Oscillator 55.20 13.27

Price Performance

Historical Comparison
FSLY
IRON

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: